
2.15 Delayed Data As of Nov 29 | ![]() Today’s Change | 1.81 Today|||52-Week Range 16.66 | -81.80% Year-to-Date |
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine Nov 29 / Zacks.com - Paid Partner Content |
Previous close | 2.01 |
Today’s open | 2.00 |
Day’s range | 2.00 - 2.36 |
Volume | 1,654,791 |
Average volume (3 months) | 2,102,808 |
Market cap | $107.8M |
Earnings growth (last year) | -203.50% |
Earnings growth (this year) | +29.90% |
Earnings growth (next 5 years) | +34.00% |
Revenue growth (last year) | -37.47% |
P/E ratio | NM |
Price/Sales | 0.53 |
Price/Book | 0.08 |
---- | ||
--Lexagene Holdings In... | 0.00 | 0.00% |
LPTXLeap Therapeutics In... | +0.03 | +1.22% |
---- |
Next reporting date | February 22, 2024 |
EPS forecast (this quarter) | $1.67 |
Annual revenue (last year) | $1.1B |
Annual profit (last year) | -$223.8M |
Net profit margin | -19.97% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |